Intuitive Surgical invested in Apreo Health, whose device competes with Zephyr Valve, which was previously approved by the FDA.
1 report, 1 independent
Updated Aug 11
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Intuitive Surgical invested in Apreo Health, whose device competes with Zephyr Valve, which was previously approved by the FDA.
Who's involved
What this event is mainly aboutKeep exploring
Part of
Corporate activity in the medical device sector in August 2025 included M&A activity (Stryker/Inari Medical, ZimVie/Archimed), competition between Medtronic and Intuitive Surgical, and the impact of Trump administration tariffs and FDA reviews.Also in this story
- FDA approved Medtronic's Hugo robotic system for urological procedures, marking a major competitive shift in the medical device sector.
- Market sentiment regarding growth rates turned disappointing for companies like Profound Medical on August 1, 2025.
- Medtronic is developing a robotic-assisted surgery system that needs regulatory approval in the US, amidst aggressive trade policy threats.
- Lemaitre, Intuitive Surgical, and Teleflex are identified as companies operating in the surgical equipment segment.
The entities involved
-
Intuitive Surgical
American corporation
-
Zephyr
Norwegian wind power company
Nothing else this week.
Coverage
Newest first; wire copies grouped- MedTech DiveApreo raises $130M for pivotal trial of emphysema device This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter.